{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:31:47Z","timestamp":1792690307595,"version":"4.5.0"},"reference-count":161,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:p>Exhaustion of T cells occurs in response to long-term exposure to self and foreign antigens. It limits T cell capacity to proliferate and produce cytokines, leading to an impaired ability to clear chronic infections or eradicate tumors. T-cell exhaustion is associated with a specific transcriptional, epigenetic, and metabolic program and characteristic cell surface markers\u2019 expression. Recent studies have begun to elucidate the role of T-cell exhaustion in transplant. Higher levels of exhausted T cells have been associated with better graft function in kidney transplant recipients. In contrast, reinvigorating exhausted T cells by immune checkpoint blockade therapies, while promoting tumor clearance, increases the risk of acute rejection. Lymphocyte depletion and high alloantigen load have been identified as major drivers of T-cell exhaustion. This could account, at least in part, for the reduced rates of acute rejection in organ transplant recipients induced with thymoglobulin and for the pro-tolerogenic effects of a large organ such as the liver. Among the drugs that are widely used for maintenance immunosuppression, calcineurin inhibitors have a contrasting inhibitory effect on exhaustion of T cells, while the influence of mTOR inhibitors is still unclear. Harnessing or encouraging the natural processes of exhaustion may provide a novel strategy to promote graft survival and transplantation tolerance.<\/jats:p>","DOI":"10.1097\/tp.0000000000003851","type":"journal-article","created":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T20:00:09Z","timestamp":1623441609000},"page":"489-499","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":39,"title":["T-cell Exhaustion in Organ Transplantation"],"prefix":"10.1097","volume":"106","author":[{"given":"Andrea","family":"Angeletti","sequence":"first","affiliation":[{"name":"Division of Nephrology, Dialysis, Transplantation, Giannina Gaslini Children\u2019s Hospital, Genoa, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Cantarelli","sequence":"additional","affiliation":[{"name":"Dipartimento di Medicina e Chirurgia, Universit\u00e0 di Parma; UO Nefrologia, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo V.","family":"Riella","sequence":"additional","affiliation":[{"name":"Department of Surgery, Center for Transplantation Sciences, Massachusetts General Hospital, Boston, MA."},{"name":"Division of Nephrology, Massachusetts General Hospital, Harvard Medical School, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Fribourg","sequence":"additional","affiliation":[{"name":"Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Cravedi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,6,9]]},"reference":[{"key":"R1-20250607","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/ni1241","article-title":"T cells and viral persistence: lessons from diverse infections.","volume":"6","author":"Klenerman","year":"2005","journal-title":"Nat Immunol"},{"key":"R2-20250607","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/362758a0","article-title":"Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells.","volume":"362","author":"Moskophidis","year":"1993","journal-title":"Nature"},{"key":"R3-20250607","first-page":"309","article-title":"Detection of cryptosporidium parvum in human feces by PCR.","volume":"23","author":"Fischer","year":"1998","journal-title":"Tokai J Exp Clin Med"},{"key":"R4-20250607","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature05115","article-title":"PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression.","volume":"443","author":"Day","year":"2006","journal-title":"Nature"},{"key":"R5-20250607","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1128\/JVI.02844-06","article-title":"Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection.","volume":"81","author":"Boni","year":"2007","journal-title":"J Virol"},{"key":"R6-20250607","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1128\/JVI.02021-06","article-title":"Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression.","volume":"81","author":"Radziewicz","year":"2007","journal-title":"J Virol"},{"key":"R7-20250607","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/imr.12823","article-title":"T-cell exhaustion in HIV infection.","volume":"292","author":"Fenwick","year":"2019","journal-title":"Immunol Rev"},{"key":"R8-20250607","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.3389\/fimmu.2019.01345","article-title":"Phenotypic evidence of T cell exhaustion and senescence during symptomatic plasmodium falciparum malaria.","volume":"10","author":"Frimpong","year":"2019","journal-title":"Front Immunol"},{"key":"R9-20250607","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3389\/fimmu.2020.00849","article-title":"Pathogenetic mechanisms of T cell dysfunction in chronic HBV infection and related therapeutic approaches.","volume":"11","author":"Fisicaro","year":"2020","journal-title":"Front Immunol"},{"key":"R10-20250607","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/9525","article-title":"Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients.","volume":"5","author":"Lee","year":"1999","journal-title":"Nat Med"},{"key":"R11-20250607","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/nature14468","article-title":"T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection.","volume":"523","author":"McKinney","year":"2015","journal-title":"Nature"},{"key":"R12-20250607","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1172\/JCI126595","article-title":"Autoreactive CD8+ T cell exhaustion distinguishes subjects with slow type 1 diabetes progression.","volume":"130","author":"Wiedeman","year":"2020","journal-title":"J Clin Invest"},{"key":"R13-20250607","doi-asserted-by":"crossref","first-page":"R130","DOI":"10.1186\/cc13941","article-title":"Persistent inflammation and T cell exhaustion in severe sepsis in the elderly.","volume":"18","author":"Inoue","year":"2014","journal-title":"Crit Care"},{"key":"R14-20250607","doi-asserted-by":"crossref","first-page":"583702","DOI":"10.3389\/fimmu.2020.583702","article-title":"Kidney failure associates with T cell exhaustion and imbalanced follicular helper T cells.","volume":"11","author":"Hartzell","year":"2020","journal-title":"Front Immunol"},{"key":"R15-20250607","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.kint.2019.01.040","article-title":"T-cell exhaustion correlates with improved outcomes in kidney transplant recipients.","volume":"96","author":"Fribourg","year":"2019","journal-title":"Kidney Int"},{"key":"R16-20250607","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/nrneph.2015.115","article-title":"Immunology: T-cell exhaustion limits immune reactivity and is associated with good prognosis in autoimmune disease.","volume":"11","author":"Carney","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"R17-20250607","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1097\/TP.0b013e31816dd64a","article-title":"Exhaustive differentiation of alloreactive CD8+ T cells: critical for determination of graft acceptance or rejection.","volume":"85","author":"Steger","year":"2008","journal-title":"Transplantation"},{"key":"R18-20250607","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1152\/advan.00066.2013","article-title":"T cell responses: naive to memory and everything in between.","volume":"37","author":"Pennock","year":"2013","journal-title":"Adv Physiol Educ"},{"key":"R19-20250607","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion.","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"R20-20250607","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nrrheum.2015.101","article-title":"Immunology: T-cell exhaustion limits immune reactivity and is associated with good prognosis in autoimmune disease.","volume":"11","author":"Carney","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"R21-20250607","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1101\/gad.314617.118","article-title":"Roles of the immune system in cancer: from tumor initiation to metastatic progression.","volume":"32","author":"Gonzalez","year":"2018","journal-title":"Genes Dev"},{"key":"R22-20250607","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/s41590-020-0760-z","article-title":"Early precursor T cells establish and propagate T cell exhaustion in chronic infection.","volume":"21","author":"Utzschneider","year":"2020","journal-title":"Nat Immunol"},{"key":"R23-20250607","article-title":"The transcription factor TCF1 in T cell differentiation and aging.","volume":"21","author":"Kim","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R24-20250607","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1111\/j.1600-6143.2012.04224.x","article-title":"Role of the PD-1 pathway in the immune response.","volume":"12","author":"Riella","year":"2012","journal-title":"Am J Transplant"},{"key":"R25-20250607","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/85330","article-title":"PD-L2 is a second ligand for PD-1 and inhibits T cell activation.","volume":"2","author":"Latchman","year":"2001","journal-title":"Nat Immunol"},{"key":"R26-20250607","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1084\/jem.20100466","article-title":"PD-1 and LAG-3 inhibitory co-receptors act synergistically to prevent autoimmunity in mice.","volume":"208","author":"Okazaki","year":"2011","journal-title":"J Exp Med"},{"key":"R27-20250607","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/s41590-018-0217-9","article-title":"LAG-3 inhibits the activation of CD4+ T cells that recognize stable pMHCII through its conformation-dependent recognition of pMHCII.","volume":"19","author":"Maruhashi","year":"2018","journal-title":"Nat Immunol"},{"key":"R28-20250607","doi-asserted-by":"crossref","first-page":"6017","DOI":"10.1074\/jbc.RA119.007455","article-title":"Atypical motifs in the cytoplasmic region of the inhibitory immune co-receptor LAG-3 inhibit T cell activation.","volume":"294","author":"Maeda","year":"2019","journal-title":"J Biol Chem"},{"key":"R29-20250607","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/S0959-8049(01)00184-8","article-title":"T Lymphocytes infiltrating various tumour types express the MHC class II ligand lymphocyte activation gene-3 (LAG-3): role of LAG-3\/MHC class II interactions in cell-cell contacts.","volume":"37","author":"Demeure","year":"2001","journal-title":"Eur J Cancer"},{"key":"R30-20250607","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/ni.1679","article-title":"Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection.","volume":"10","author":"Blackburn","year":"2009","journal-title":"Nat Immunol"},{"key":"R31-20250607","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/intimm\/dxp107","article-title":"On the role of the inhibitory receptor LAG-3 in acute and chronic LCMV infection.","volume":"22","author":"Richter","year":"2010","journal-title":"Int Immunol"},{"key":"R32-20250607","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/ni.1674","article-title":"The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells.","volume":"10","author":"Yu","year":"2009","journal-title":"Nat Immunol"},{"key":"R33-20250607","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.4049\/jimmunol.1003081","article-title":"Cutting edge: TIGIT has T cell-intrinsic inhibitory functions.","volume":"186","author":"Joller","year":"2011","journal-title":"J Immunol"},{"key":"R34-20250607","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.immuni.2016.05.001","article-title":"Lag-3, tim-3, and TIGIT: co-inhibitory receptors with specialized functions in immune regulation.","volume":"44","author":"Anderson","year":"2016","journal-title":"Immunity"},{"key":"R35-20250607","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1084\/jem.20081398","article-title":"Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection.","volume":"205","author":"Jones","year":"2008","journal-title":"J Exp Med"},{"key":"R36-20250607","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nri2762","article-title":"FcgammaRIIB in autoimmunity and infection: evolutionary and therapeutic implications.","volume":"10","author":"Smith","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"R37-20250607","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1111\/ajt.15837","article-title":"Memory T cell-mediated rejection is mitigated by Fc\u03b3RIIB expression on CD8+ T cells.","volume":"20","author":"Morris","year":"2020","journal-title":"Am J Transplant"},{"key":"R38-20250607","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.immuni.2019.12.006","article-title":"Signaling through the inhibitory Fc receptor Fc\u03b3RIIB induces CD8+ T cell apoptosis to limit T cell immunity.","volume":"52","author":"Morris","year":"2020","journal-title":"Immunity"},{"key":"R39-20250607","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/imm.12354","article-title":"The regulatory T cell effector molecule fibrinogen-like protein 2 is necessary for the development of rapamycin-induced tolerance to fully MHC-mismatched murine cardiac allografts.","volume":"144","author":"Urbanellis","year":"2015","journal-title":"Immunology"},{"key":"R40-20250607","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1111\/ajt.13696","article-title":"Overexpression of fibrinogen-like protein 2 promotes tolerance in a fully mismatched murine model of heart transplantation.","volume":"16","author":"Bartczak","year":"2016","journal-title":"Am J Transplant"},{"key":"R41-20250607","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1681\/ASN.2011100967","article-title":"Cellular senescence limits regenerative capacity and allograft survival.","volume":"23","author":"Braun","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"R42-20250607","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/ajt.13092","article-title":"ATG-induced accelerated immune senescence: clinical implications in renal transplant recipients.","volume":"15","author":"Crepin","year":"2015","journal-title":"Am J Transplant"},{"key":"R43-20250607","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41577-020-00454-2","article-title":"Rethinking peripheral T cell tolerance: checkpoints across a T cell\u2019s journey.","volume":"21","author":"ElTanbouly","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"R44-20250607","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1056\/NEJM199812243392607","article-title":"Antigen localization and migration in immunity and tolerance.","volume":"339","author":"Starzl","year":"1998","journal-title":"N Engl J Med"},{"key":"R45-20250607","doi-asserted-by":"crossref","first-page":"5313","DOI":"10.4049\/jimmunol.181.8.5313","article-title":"PD-1-dependent mechanisms maintain peripheral tolerance of donor-reactive CD8+ T cells to transplanted tissue.","volume":"181","author":"Koehn","year":"2008","journal-title":"J Immunol"},{"key":"R46-20250607","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1002\/eji.200737583","article-title":"Programmed cell death 1 (PD-1) and its ligand PD-L1 are required for allograft tolerance.","volume":"37","author":"Wang","year":"2007","journal-title":"Eur J Immunol"},{"key":"R47-20250607","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/(SICI)1521-4141(199902)29:02<686::AID-IMMU686>3.0.CO;2-N","article-title":"Anergic T cells act as suppressor cells in vitro and in vivo.","volume":"29","author":"Chai","year":"1999","journal-title":"Eur J Immunol"},{"key":"R48-20250607","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1097\/01.ASN.0000042163.73539.D4","article-title":"Reversibility with interleukin-2 suggests that T cell anergy contributes to donor-specific hyporesponsiveness in renal transplant patients.","volume":"13","author":"Ng","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"R49-20250607","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41586-019-1325-x","article-title":"TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion.","volume":"571","author":"Khan","year":"2019","journal-title":"Nature"},{"key":"R50-20250607","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/MOT.0000000000000153","article-title":"T-cell exhaustion in allograft rejection and tolerance.","volume":"20","author":"Thorp","year":"2015","journal-title":"Curr Opin Organ Transplant"},{"key":"R51-20250607","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1111\/ajt.16372","article-title":"Harnessing T cell exhaustion to improve solid organ transplant outcomes.","volume":"21","author":"Levitsky","year":"2021","journal-title":"Am J Transplant"},{"key":"R52-20250607","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1001\/archsurg.134.9.971","article-title":"Excellent outcome in recipients of dual kidney transplants: a report of the first 50 dual kidney transplants at Stanford University.","volume":"134","author":"Lu","year":"1999","journal-title":"Arch Surg"},{"key":"R53-20250607","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1146\/annurev.immunol.21.120601.141110","article-title":"T cell anergy.","volume":"21","author":"Schwartz","year":"2003","journal-title":"Annu Rev Immunol"},{"key":"R54-20250607","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.0105-2896.2006.00382.x","article-title":"Signals required for programming effector and memory development by CD8+ T cells.","volume":"211","author":"Mescher","year":"2006","journal-title":"Immunol Rev"},{"key":"R55-20250607","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/ni1398","article-title":"A pathway regulated by cell cycle inhibitor p27Kip1 and checkpoint inhibitor Smad3 is involved in the induction of T cell tolerance.","volume":"7","author":"Li","year":"2006","journal-title":"Nat Immunol"},{"key":"R56-20250607","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.it.2013.10.001","article-title":"Tolerance and exhaustion: defining mechanisms of T cell dysfunction.","volume":"35","author":"Schietinger","year":"2014","journal-title":"Trends Immunol"},{"key":"R57-20250607","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1681\/ASN.V1061356","article-title":"T cell costimulatory blockade: new therapies for transplant rejection.","volume":"10","author":"Gudmundsdottir","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"R58-20250607","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0092-8674(02)00767-5","article-title":"Transcriptional mechanisms underlying lymphocyte tolerance.","volume":"109","author":"Maci\u00e1n","year":"2002","journal-title":"Cell"},{"key":"R59-20250607","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.immuni.2007.09.006","article-title":"Molecular signature of CD8+ T cell exhaustion during chronic viral infection.","volume":"27","author":"Wherry","year":"2007","journal-title":"Immunity"},{"key":"R60-20250607","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.immuni.2015.01.006","article-title":"The transcription factor NFAT promotes exhaustion of activated CD8+ T cells.","volume":"42","author":"Martinez","year":"2015","journal-title":"Immunity"},{"key":"R61-20250607","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1158\/0008-5472.CAN-17-3297","article-title":"NFATc1 promotes antitumoral effector functions and memory CD8+ T-cell differentiation during non-small cell lung cancer development.","volume":"78","author":"Heim","year":"2018","journal-title":"Cancer Res"},{"key":"R62-20250607","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ebiom.2017.03.027","article-title":"Telomeres and cell senescence - size matters not.","volume":"21","author":"Victorelli","year":"2017","journal-title":"Ebiomedicine"},{"key":"R63-20250607","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0014-4827(61)90192-6","article-title":"The serial cultivation of human diploid cell strains.","volume":"25","author":"Hayflick","year":"1961","journal-title":"Exp Cell Res"},{"key":"R64-20250607","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.tcb.2018.02.001","article-title":"Hallmarks of cellular senescence.","volume":"28","author":"Hernandez-Segura","year":"2018","journal-title":"Trends Cell Biol"},{"key":"R65-20250607","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.it.2009.03.013","article-title":"CD28(-) T cells: their role in the age-associated decline of immune function.","volume":"30","author":"Weng","year":"2009","journal-title":"Trends Immunol"},{"key":"R66-20250607","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nature13193","article-title":"The role of senescent cells in ageing.","volume":"509","author":"van Deursen","year":"2014","journal-title":"Nature"},{"key":"R67-20250607","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.cell.2017.05.015","article-title":"Senescence in health and disease.","volume":"169","author":"He","year":"2017","journal-title":"Cell"},{"key":"R68-20250607","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humimm.2005.11.005","article-title":"Foxp3 expressing CD4+ CD25+ and CD8+CD28- T regulatory cells in the peripheral blood of patients with lung cancer and pleural mesothelioma.","volume":"67","author":"Meloni","year":"2006","journal-title":"Hum Immunol"},{"key":"R69-20250607","first-page":"779","article-title":"Down-regulation of CD28, TCR-zeta (zeta) and up-regulation of FAS in peripheral cytotoxic T-cells of primary breast cancer patients.","volume":"28","author":"Gruber","year":"2008","journal-title":"Anticancer Res"},{"key":"R70-20250607","doi-asserted-by":"crossref","first-page":"5777","DOI":"10.1002\/cncr.25371","article-title":"Clinical significance of regulatory T cells and CD8+ effector populations in patients with human endometrial carcinoma.","volume":"116","author":"Chang","year":"2010","journal-title":"Cancer"},{"key":"R71-20250607","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ygyno.2010.05.016","article-title":"Profound elevation of CD8+ T cells expressing the intraepithelial lymphocyte marker CD103 (alphaE\/beta7 Integrin) in high-grade serous ovarian cancer.","volume":"118","author":"Webb","year":"2010","journal-title":"Gynecol Oncol"},{"key":"R72-20250607","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s10875-006-9040-4","article-title":"Ex-vivo analysis of CD8+ T cells infiltrating colorectal tumors identifies a major effector-memory subset with low perforin content.","volume":"26","author":"Ye","year":"2006","journal-title":"J Clin Immunol"},{"key":"R73-20250607","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41423-019-0344-8","article-title":"Exhaustion and senescence: two crucial dysfunctional states of T cells in the tumor microenvironment.","volume":"17","author":"Zhao","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"R74-20250607","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1158\/0008-5472.CAN-07-2282","article-title":"Tumor-induced senescent T cells with suppressor function: a potential form of tumor immune evasion.","volume":"68","author":"Montes","year":"2008","journal-title":"Cancer Res"},{"key":"R75-20250607","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1056\/NEJMra1402513","article-title":"The key role of epigenetics in human disease prevention and mitigation.","volume":"378","author":"Feinberg","year":"2018","journal-title":"N Engl J Med"},{"key":"R76-20250607","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/cr.2011.22","article-title":"Regulation of chromatin by histone modifications.","volume":"21","author":"Bannister","year":"2011","journal-title":"Cell Res"},{"key":"R77-20250607","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/s41580-018-0074-2","article-title":"Functions and mechanisms of epigenetic inheritance in animals.","volume":"19","author":"Skvortsova","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R78-20250607","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1126\/science.aaf2807","article-title":"Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade.","volume":"354","author":"Pauken","year":"2016","journal-title":"Science"},{"key":"R79-20250607","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1126\/science.aae0491","article-title":"The epigenetic landscape of T cell exhaustion.","volume":"354","author":"Sen","year":"2016","journal-title":"Science"},{"key":"R80-20250607","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.immuni.2010.07.006","article-title":"Maintaining cell identity through global control of genomic organization.","volume":"33","author":"Natoli","year":"2010","journal-title":"Immunity"},{"key":"R81-20250607","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev-immunol-041015-055318","article-title":"CD8 T cell exhaustion during chronic viral infection and cancer.","volume":"37","author":"McLane","year":"2019","journal-title":"Annu Rev Immunol"},{"key":"R82-20250607","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/s41590-019-0403-4","article-title":"Single-cell RNA-seq reveals TOX as a key regulator of CD8+ T cell persistence in chronic infection.","volume":"20","author":"Yao","year":"2019","journal-title":"Nat Immunol"},{"key":"R83-20250607","doi-asserted-by":"crossref","first-page":"14113","DOI":"10.1073\/pnas.1903520116","article-title":"Epigenetic signature of PD-1+ TCF1+ CD8 T cells that act as resource cells during chronic viral infection and respond to PD-1 blockade.","volume":"116","author":"Jadhav","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R84-20250607","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/nm.2446","article-title":"A human memory T cell subset with stem cell-like properties.","volume":"17","author":"Gattinoni","year":"2011","journal-title":"Nat Med"},{"key":"R85-20250607","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-019-1324-y","article-title":"TOX is a critical regulator of tumour-specific T cell differentiation.","volume":"571","author":"Scott","year":"2019","journal-title":"Nature"},{"key":"R86-20250607","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41590-019-0312-6","article-title":"Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade.","volume":"20","author":"Miller","year":"2019","journal-title":"Nat Immunol"},{"key":"R87-20250607","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.immuni.2011.06.015","article-title":"Chronic virus infection enforces demethylation of the locus that encodes PD-1 in antigen-specific CD8(+) T cells.","volume":"35","author":"Youngblood","year":"2011","journal-title":"Immunity"},{"key":"R88-20250607","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-019-1326-9","article-title":"TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection.","volume":"571","author":"Alfei","year":"2019","journal-title":"Nature"},{"key":"R89-20250607","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1084\/jem.20142237","article-title":"Genetic absence of PD-1 promotes accumulation of terminally differentiated exhausted CD8+ T cells.","volume":"212","author":"Odorizzi","year":"2015","journal-title":"J Exp Med"},{"key":"R90-20250607","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.molmed.2016.10.002","article-title":"Cell-intrinsic barriers of T cell-based immunotherapy.","volume":"22","author":"Ghoneim","year":"2016","journal-title":"Trends Mol Med"},{"key":"R91-20250607","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1097\/TP.0000000000001720","article-title":"Epigenetic remodeling in exhausted T cells: implications for transplantation tolerance.","volume":"101","author":"Laurie","year":"2017","journal-title":"Transplantation"},{"key":"R92-20250607","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/TP.0000000000000878","article-title":"Epigenetics in kidney transplantation: current evidence, predictions, and future research directions.","volume":"100","author":"Mas","year":"2016","journal-title":"Transplantation"},{"key":"R93-20250607","doi-asserted-by":"crossref","first-page":"694","DOI":"10.4161\/epi.25201","article-title":"Epigenetic modulation of the immune function: a potential target for tolerance.","volume":"8","author":"Su\u00e1rez-\u00c1lvarez","year":"2013","journal-title":"Epigenetics"},{"key":"R94-20250607","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13148-016-0288-0","article-title":"Variations in DNA methylation of interferon gamma and programmed death 1 in allograft rejection after kidney transplantation.","volume":"8","author":"Boer","year":"2016","journal-title":"Clin Epigenetics"},{"key":"R95-20250607","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s13287-019-1245-6","article-title":"DNA methylation dynamic of bone marrow hematopoietic stem cells after allogeneic transplantation.","volume":"10","author":"Trino","year":"2019","journal-title":"Stem Cell Res Ther"},{"key":"R96-20250607","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1470-2045(13)70512-6","article-title":"Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell transplantation: a phase 1\/2 trial.","volume":"15","author":"Choi","year":"2014","journal-title":"Lancet Oncol"},{"key":"R97-20250607","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1182\/blood-2017-06-790469","article-title":"Vorinostat plus tacrolimus\/methotrexate to prevent GVHD after myeloablative conditioning, unrelated donor HCT.","volume":"130","author":"Choi","year":"2017","journal-title":"Blood"},{"key":"R98-20250607","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1038\/leu.2017.242","article-title":"Phase I\/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial).","volume":"31","author":"Bug","year":"2017","journal-title":"Leukemia"},{"key":"R99-20250607","doi-asserted-by":"crossref","first-page":"4430","DOI":"10.1182\/bloodadvances.2020002074","article-title":"Panobinostat and decitabine prior to donor lymphocyte infusion in allogeneic stem cell transplantation.","volume":"4","author":"Kalin","year":"2020","journal-title":"Blood Adv"},{"key":"R100-20250607","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1084\/jem.20151159","article-title":"T cell metabolism drives immunity.","volume":"212","author":"Buck","year":"2015","journal-title":"J Exp Med"},{"key":"R101-20250607","doi-asserted-by":"crossref","first-page":"1242454","DOI":"10.1126\/science.1242454","article-title":"Fueling immunity: insights into metabolism and lymphocyte function.","volume":"342","author":"Pearce","year":"2013","journal-title":"Science"},{"key":"R102-20250607","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1146\/annurev-immunol-032712-095956","article-title":"Metabolic regulation of T lymphocytes.","volume":"31","author":"MacIver","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"R103-20250607","doi-asserted-by":"crossref","first-page":"6692","DOI":"10.1038\/ncomms7692","article-title":"PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation.","volume":"6","author":"Patsoukis","year":"2015","journal-title":"Nat Commun"},{"key":"R104-20250607","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.immuni.2016.07.008","article-title":"Bioenergetic insufficiencies due to metabolic alterations regulated by the inhibitory receptor PD-1 are an early driver of CD8(+) T cell exhaustion.","volume":"45","author":"Bengsch","year":"2016","journal-title":"Immunity"},{"key":"R105-20250607","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1126\/science.aaf1292","article-title":"T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition.","volume":"355","author":"Hui","year":"2017","journal-title":"Science"},{"key":"R106-20250607","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1126\/science.aaf0683","article-title":"Rescue of exhausted CD8 T cells by PD-1-targeted therapies is CD28-dependent.","volume":"355","author":"Kamphorst","year":"2017","journal-title":"Science"},{"key":"R107-20250607","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.celrep.2016.06.078","article-title":"Distinct metabolic requirements of exhausted and functional virus-specific CD8 T cells in the same host.","volume":"16","author":"Schurich","year":"2016","journal-title":"Cell Rep"},{"key":"R108-20250607","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.cell.2015.08.052","article-title":"Melanoma Cell-intrinsic PD-1 receptor functions promote tumor growth.","volume":"162","author":"Kleffel","year":"2015","journal-title":"Cell"},{"key":"R109-20250607","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","article-title":"Metabolic competition in the tumor microenvironment is a driver of cancer progression.","volume":"162","author":"Chang","year":"2015","journal-title":"Cell"},{"key":"R110-20250607","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.immuni.2016.07.009","article-title":"The tumor microenvironment represses T cell mitochondrial biogenesis to drive intratumoral T cell metabolic insufficiency and dysfunction.","volume":"45","author":"Scharping","year":"2016","journal-title":"Immunity"},{"key":"R111-20250607","doi-asserted-by":"crossref","first-page":"6095","DOI":"10.4049\/jimmunol.0803510","article-title":"Anergic T cells are metabolically anergic.","volume":"183","author":"Zheng","year":"2009","journal-title":"J Immunol"},{"key":"R112-20250607","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cmet.2014.05.004","article-title":"The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function.","volume":"20","author":"Macintyre","year":"2014","journal-title":"Cell Metab"},{"key":"R113-20250607","doi-asserted-by":"crossref","first-page":"67ra8","DOI":"10.1126\/scitranslmed.3001975","article-title":"Manipulating the bioenergetics of alloreactive T cells causes their selective apoptosis and arrests graft-versus-host disease.","volume":"3","author":"Gatza","year":"2011","journal-title":"Sci Transl Med"},{"key":"R114-20250607","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.trsl.2016.03.006","article-title":"Metformin attenuates graft-versus-host disease via restricting mammalian target of rapamycin\/signal transducer and activator of transcription 3 and promoting adenosine monophosphate-activated protein kinase-autophagy for the balance between T helper 17 and Tregs.","volume":"173","author":"Park","year":"2016","journal-title":"Transl Res"},{"key":"R115-20250607","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1182\/blood-2013-04-495515","article-title":"Effector T cells require fatty acid metabolism during murine graft-versus-host disease.","volume":"122","author":"Byersdorfer","year":"2013","journal-title":"Blood"},{"key":"R116-20250607","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.molimm.2015.07.023","article-title":"Rethinking the paradigm: how comparative studies on fatty acid oxidation inform our understanding of T cell metabolism.","volume":"68","author":"Chiaranunt","year":"2015","journal-title":"Mol Immunol"},{"key":"R117-20250607","doi-asserted-by":"crossref","first-page":"240","DOI":"10.4049\/jimmunol.172.1.240","article-title":"Effects of T cell frequency and graft size on transplant outcome in mice.","volume":"172","author":"He","year":"2004","journal-title":"J Immunol"},{"key":"R118-20250607","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.imbio.2011.01.007","article-title":"The role of co-inhibitory signals in spontaneous tolerance of weakly mismatched transplants.","volume":"216","author":"Thangavelu","year":"2011","journal-title":"Immunobiology"},{"key":"R119-20250607","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1097\/TP.0000000000000842","article-title":"A Rationale for age-adapted immunosuppression in organ transplantation.","volume":"99","author":"Krenzien","year":"2015","journal-title":"Transplantation"},{"key":"R120-20250607","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1097\/TP.0000000000002786","article-title":"Changes of T-cell immunity over a lifetime.","volume":"103","author":"Nian","year":"2019","journal-title":"Transplantation"},{"key":"R121-20250607","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3389\/fimmu.2013.00475","article-title":"Clonal exhaustion as a mechanism to protect against severe immunopathology and death from an overwhelming CD8 T cell response.","volume":"4","author":"Cornberg","year":"2013","journal-title":"Front Immunol"},{"key":"R122-20250607","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1097\/00007890-199612270-00005","article-title":"Tolerance to rat liver allografts: IV. Acceptance depends on the quantity of donor tissue and on donor leukocytes.","volume":"62","author":"Sun","year":"1996","journal-title":"Transplantation"},{"key":"R123-20250607","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1111\/ajt.15870","article-title":"T cell exhaustion is associated with antigen abundance and promotes transplant acceptance.","volume":"20","author":"Zou","year":"2020","journal-title":"Am J Transplant"},{"key":"R124-20250607","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1681\/ASN.2009121296","article-title":"Kidney and recipient weight incompatibility reduces long-term graft survival.","volume":"21","author":"Giral","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"R125-20250607","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1056\/NEJMra033540","article-title":"Immunosuppressive drugs for kidney transplantation.","volume":"351","author":"Halloran","year":"2004","journal-title":"N Engl J Med"},{"key":"R126-20250607","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/ajt.13884","article-title":"Induction therapy for kidney transplant recipients: do we still need anti-IL2 receptor monoclonal antibodies?","volume":"17","author":"Hellemans","year":"2017","journal-title":"Am J Transplant"},{"key":"R127-20250607","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1097\/TP.0000000000003192","article-title":"Assessing the complex causes of kidney allograft loss.","volume":"104","author":"Van Loon","year":"2020","journal-title":"Transplantation"},{"key":"R128-20250607","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1146\/annurev-immunol-042718-041717","article-title":"Regulatory T cells and human disease.","volume":"38","author":"Sakaguchi","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"R129-20250607","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/s41409-018-0162-0","article-title":"Homeostatic proliferation leads to telomere attrition and increased PD-1 expression after autologous hematopoietic SCT for systemic sclerosis.","volume":"53","author":"Arruda","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"R130-20250607","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1056\/NEJMoa060068","article-title":"Rabbit antithymocyte globulin versus basiliximab in renal transplantation.","volume":"355","author":"Brennan","year":"2006","journal-title":"N Engl J Med"},{"key":"R131-20250607","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1097\/01.tp.0000219817.18049.36","article-title":"Disassociation between risk of graft loss and risk of non-Hodgkin lymphoma with induction agents in renal transplant recipients.","volume":"81","author":"Opelz","year":"2006","journal-title":"Transplantation"},{"key":"R132-20250607","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1111\/ajt.15979","article-title":"Distinct peripheral blood molecular signature emerges with successful tacrolimus withdrawal in kidney transplant recipients.","volume":"20","author":"Cravedi","year":"2020","journal-title":"Am J Transplant"},{"key":"R133-20250607","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/TP.0000000000001902","article-title":"Rapamycin prolongs graft survival and induces CD4+IFN-\u03b3+IL-10+ regulatory type 1 cells in old recipient mice.","volume":"102","author":"Quante","year":"2018","journal-title":"Transplantation"},{"key":"R134-20250607","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.3389\/fimmu.2019.02978","article-title":"Effects of antirejection drugs on innate immune cells after kidney transplantation.","volume":"10","author":"Zaza","year":"2019","journal-title":"Front Immunol"},{"key":"R135-20250607","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13045-019-0754-1","article-title":"Targeting mTOR for cancer therapy.","volume":"12","author":"Hua","year":"2019","journal-title":"J Hematol Oncol"},{"key":"R136-20250607","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMoa1204166","article-title":"Sirolimus and secondary skin-cancer prevention in kidney transplantation.","volume":"367","author":"Euvrard","year":"2012","journal-title":"N Engl J Med"},{"key":"R137-20250607","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1056\/NEJMc1614298","article-title":"Preserved renal-allograft function and the PD-1 pathway inhibitor nivolumab.","volume":"376","author":"Barnett","year":"2017","journal-title":"N Engl J Med"},{"key":"R138-20250607","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1038\/s41467-019-12628-1","article-title":"Targeting the mTOR pathway uncouples the efficacy and toxicity of PD-1 blockade in renal transplantation.","volume":"10","author":"Esfahani","year":"2019","journal-title":"Nat Commun"},{"key":"R139-20250607","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/ijc.31769","article-title":"Optimal oncologic management and mTOR inhibitor introduction are safe and improve survival in kidney and liver allograft recipients with de novo carcinoma.","volume":"144","author":"Rousseau","year":"2019","journal-title":"Int J Cancer"},{"key":"R140-20250607","doi-asserted-by":"crossref","first-page":"574271","DOI":"10.3389\/fimmu.2020.574271","article-title":"The use of immune checkpoint inhibitors in oncology and the occurrence of AKI: where do we stand?","volume":"11","author":"Franzin","year":"2020","journal-title":"Front Immunol"},{"key":"R141-20250607","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/imr.12845","article-title":"mTOR signaling at the crossroads of environmental signals and T-cell fate decisions.","volume":"295","author":"Huang","year":"2020","journal-title":"Immunol Rev"},{"key":"R142-20250607","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.immuni.2014.10.013","article-title":"The transcription factor FoxO1 sustains expression of the inhibitory receptor PD-1 and survival of antiviral CD8(+) T cells during chronic infection.","volume":"41","author":"Staron","year":"2014","journal-title":"Immunity"},{"key":"R143-20250607","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1097\/QAD.0000000000001997","article-title":"mTOR signaling mediates effects of common gamma-chain cytokines on T cell proliferation and exhaustion: implications for HIV-1 persistence and cure research.","volume":"32","author":"Taylor","year":"2018","journal-title":"AIDS"},{"key":"R144-20250607","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.4049\/jimmunol.2000736","article-title":"Functional characteristics and phenotypic plasticity of CD57+PD1- CD4 T cells and their relationship with transplant immunosuppression.","volume":"206","author":"Shaw","year":"2021","journal-title":"J Immunol"},{"key":"R145-20250607","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1056\/NEJMoa1712126","article-title":"Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinoma.","volume":"378","author":"Motzer","year":"2018","journal-title":"N Engl J Med"},{"key":"R146-20250607","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1038\/s41467-020-17670-y","article-title":"A decade of immune-checkpoint inhibitors in cancer therapy.","volume":"11","author":"Robert","year":"2020","journal-title":"Nat Commun"},{"key":"R147-20250607","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1056\/NEJMoa1412082","article-title":"Nivolumab in previously untreated melanoma without BRAF mutation.","volume":"372","author":"Robert","year":"2015","journal-title":"N Engl J Med"},{"key":"R148-20250607","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1470-2045(15)70076-8","article-title":"Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial.","volume":"16","author":"Weber","year":"2015","journal-title":"Lancet Oncol"},{"key":"R149-20250607","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejca.2017.07.022","article-title":"Final analysis of a randomised trial comparing pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory advanced melanoma.","volume":"86","author":"Hamid","year":"2017","journal-title":"Eur J Cancer"},{"key":"R150-20250607","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1200\/JCO.2013.49.2314","article-title":"Successful administration of ipilimumab to two kidney transplantation patients with metastatic melanoma.","volume":"32","author":"Lipson","year":"2014","journal-title":"J Clin Oncol"},{"key":"R151-20250607","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1111\/ajt.13711","article-title":"Checkpoint inhibitors in kidney transplant recipients and the potential risk of rejection.","volume":"16","author":"Alhamad","year":"2016","journal-title":"Am J Transplant"},{"key":"R152-20250607","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMc1509268","article-title":"Tumor regression and allograft rejection after administration of anti-PD-1.","volume":"374","author":"Lipson","year":"2016","journal-title":"N Engl J Med"},{"key":"R153-20250607","doi-asserted-by":"crossref","first-page":"e291","DOI":"10.1097\/TP.0000000000001861","article-title":"Severe allograft rejection and autoimmune hemolytic anemia after Anti-PD1 therapy in a kidney transplanted patient.","volume":"101","author":"Deltombe","year":"2017","journal-title":"Transplantation"},{"key":"R154-20250607","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s40425-019-0585-1","article-title":"Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature.","volume":"7","author":"Abdel-Wahab","year":"2019","journal-title":"J Immunother Cancer"},{"key":"R155-20250607","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/CCO.0000000000000505","article-title":"Immune checkpoint blockade for organ transplant patients with advanced cancer: how far can we go?","volume":"31","author":"De Bruyn","year":"2019","journal-title":"Curr Opin Oncol"},{"key":"R156-20250607","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1097\/TP.0000000000002914","article-title":"Poor outcomes with the use of checkpoint inhibitors in kidney transplant recipients.","volume":"104","author":"Venkatachalam","year":"2020","journal-title":"Transplantation"},{"key":"R157-20250607","article-title":"A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant.","author":"Murakami","year":"2020","journal-title":"Kidney Int"},{"key":"R158-20250607","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/TP.0000000000000169","article-title":"Co-inhibitory pathways and their importance in immune regulation.","volume":"98","author":"Murakami","year":"2014","journal-title":"Transplantation"},{"key":"R159-20250607","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1038\/s41590-020-0769-3","article-title":"The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies.","volume":"21","author":"Kumagai","year":"2020","journal-title":"Nat Immunol"},{"key":"R160-20250607","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMra1703481","article-title":"Immune-related adverse events associated with immune checkpoint blockade.","volume":"378","author":"Postow","year":"2018","journal-title":"N Engl J Med"},{"key":"R161-20250607","doi-asserted-by":"crossref","first-page":"e201611","DOI":"10.1001\/jamanetworkopen.2020.1611","article-title":"Immune checkpoint inhibitors and immune-related adverse events in patients with advanced melanoma: a systematic review and network meta-analysis.","volume":"3","author":"Chang","year":"2020","journal-title":"JAMA Netw Open"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003851","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T16:13:24Z","timestamp":1749312804000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,9]]},"references-count":161,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000003851","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6,9]]}}}